|
This email is being sent to approved COVID-19 Vaccine Program Providers, Local Health Jurisdictions, and Emergency Preparedness Contacts.
Dear COVID-19 Vaccine Partners,
On August 19, 2022, the U.S. Food & Drug Administration authorized the emergency use of the Novavax COVID-19 Vaccine in individuals 12 through 17 years of age. They analyzed the vaccine in this age group and found it to be safe and effective. The vaccine was previously authorized for individuals 18 years and older.
The Centers for Disease Control and Prevention (CDC) has also agreed that Novavax’s COVID-19 vaccine may be used as another primary series option for adolescents ages 12 through 17.
The Washington State Department of Health has updated its standing orders to follow this new age recommendation. The updated standing orders can be viewed here.
This broadens the choices parents have when selecting a vaccine for their adolescent. The Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines continue to be available for children ages 6 months and older. It is important to vaccinate youth against COVID-19 in order to reduce their chance of getting seriously ill.
In partnership,
COVID-19 Vaccine Program
Prevention and Community Health Division
Washington State Department of Health
COVID.vaccine@doh.wa.gov
360-236-3873 | www.doh.wa.gov
|
